AssetMark’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$492 Buy
32
+16
+100% +$238 ﹤0.01% 3412
2026
Q2
$208 Hold
16
– – ﹤0.01% 3421
2026
Q1
$182 Hold
16
– – ﹤0.01% 3332
2025
Q4
$205 Hold
16
– – ﹤0.01% 3251
2025
Q3
$179 Hold
16
– – ﹤0.01% 3080
2025
Q2
$159 Sell
16
-33
-67% -$323 ﹤0.01% 2905
2025
Q1
$460 Sell
49
-49
-50% -$515 ﹤0.01% 2430
2024
Q4
$898 Buy
98
+74
+308% +$544 ﹤0.01% 2261
2024
Q3
$187 Buy
+24
New +$173 ﹤0.01% 2170
2018
Q1
– Sell
-12
Closed – – 1426
2017
Q4
$0 Sell
12
-254
-95% -$4.33K ﹤0.01% 1862
2017
Q3
$5K Buy
266
+78
+41% +$1.31K ﹤0.01% 1137
2017
Q2
$3K Buy
188
+126
+203% +$1.99K ﹤0.01% 1165
2017
Q1
$1K Buy
+62
New +$1.04K ﹤0.01% 1184

Other funds holding ANGO

AssetMark's ANGO Position: Q3 2026 in Review

AssetMark increased its AngioDynamics (ANGO) stake by 100% in Q3 2026, buying an estimated $238 and bringing the position to 32 shares worth $492. The position accounts for ﹤0.01% of the portfolio, ranked #3412.

AssetMark first reported a position in ANGO in Q1 2017 and has held it in 13 quarters since. The position peaked at $5K in Q3 2017. 122 funds tracked by Wall St. Rank hold ANGO as of Q3 2026.

  • AssetMark held 32 shares of AngioDynamics worth $492 as of Q3 2026.
  • AssetMark bought 16 AngioDynamics shares in Q3 2026, an estimated $238.
  • AngioDynamics made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #3412 holding.
  • AssetMark first reported a position in AngioDynamics in Q1 2017 and has held it in 13 quarters since.
  • AssetMark's AngioDynamics position peaked at $5K in Q3 2017.
  • 122 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2026.

Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.